West Pharmaceutical Services Engages in Upcoming Investor Conferences
West Pharmaceutical Services, Inc. (NYSE: WST), a renowned leader in innovative solutions for injectable drug administration, is excited to announce its participation in significant investor conferences. These upcoming events provide a valuable opportunity for the company to connect with investors and showcase its industry leadership.
Details of Upcoming Presentations
West Pharmaceutical Services will present at the Barclays 27th Annual Global Healthcare Conference. This prominent event is scheduled for a date in mid-March, where company representatives will discuss key strategies and advancements in their product offerings.
In addition to the Barclays conference, West will also take part in the KBCM Healthcare Forum. This event will occur the following week, further allowing the company to engage with the investment community. Attendees can look forward to insightful presentations about the company's direction in the injectable solutions market.
Accessing the Presentations
A live audio webcast of both conferences will be accessible in the "Investors" section of West's official website. Those interested in the insights shared at these conferences can listen to the events live or access a replay available for approximately 90 days afterward, ensuring broad access to information on the company’s progress and innovation.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc. is at the forefront of providing innovative, high-quality injectable solutions and services. As a trusted partner for both established and emerging pharmaceutical developers, West plays a crucial role in ensuring the safe and effective containment and delivery of life-saving and life-enhancing medicines.
The company boasts a robust workforce of over 10,000 team members across 50 sites, including 25 manufacturing facilities worldwide. This extensive operation allows West to deliver an impressive volume of over 41 billion components and devices each year, fundamentally supporting its customers in their missions to improve patient care.
Headquartered in Exton, Pennsylvania, West announced a strong performance, with fiscal year 2024 net sales reaching $2.89 billion. Not only is West traded on the New York Stock Exchange under the ticker symbol WST, but it is also a proud member of the Standard & Poor's 500 index, reflecting its solid standing in the industry.
For more information about West Pharmaceutical Services and their offerings, visit their website.
Frequently Asked Questions
What is West Pharmaceutical Services known for?
West Pharmaceutical Services specializes in innovative solutions for injectable drug administration, focusing on quality and safety in drug delivery.
Where does West Pharmaceutical Services operate?
West has over 50 sites globally, including 25 manufacturing facilities, offering support to customers worldwide.
When will West present at the investor conferences?
West will present at the Barclays conference in March and also at the KBCM Healthcare Forum on a date later that month.
How can I access the presentations?
The presentations will be available through a live audio webcast on West's official website, with replays accessible for about 90 days.
What are the financial highlights of West for 2024?
In fiscal year 2024, West Pharmaceutical Services generated $2.89 billion in net sales, showcasing its strong market position and operational success.